Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

184 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of infliximab in very early onset inflammatory bowel disease: a national comparative retrospective study.
Bramuzzo M, Arrigo S, Romano C, Filardi MC, Lionetti P, Agrusti A, Dipasquale V, Paci M, Zuin G, Aloi M, Strisciuglio C, Miele E, Pastore M, Martelossi S, Alvisi P; SIGENP IBD Working Group. Bramuzzo M, et al. Among authors: lionetti p. United European Gastroenterol J. 2019 Jul;7(6):759-766. doi: 10.1177/2050640619847592. Epub 2019 Apr 25. United European Gastroenterol J. 2019. PMID: 31316780 Free PMC article.
VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study.
Guandalini S, Magazzù G, Chiaro A, La Balestra V, Di Nardo G, Gopalan S, Sibal A, Romano C, Canani RB, Lionetti P, Setty M. Guandalini S, et al. Among authors: lionetti p. J Pediatr Gastroenterol Nutr. 2010 Jul;51(1):24-30. doi: 10.1097/MPG.0b013e3181ca4d95. J Pediatr Gastroenterol Nutr. 2010. PMID: 20453678 Clinical Trial.
ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents.
Levine A, Koletzko S, Turner D, Escher JC, Cucchiara S, de Ridder L, Kolho KL, Veres G, Russell RK, Paerregaard A, Buderus S, Greer ML, Dias JA, Veereman-Wauters G, Lionetti P, Sladek M, Martin de Carpi J, Staiano A, Ruemmele FM, Wilson DC; European Society of Pediatric Gastroenterology, Hepatology, and Nutrition. Levine A, et al. Among authors: lionetti p. J Pediatr Gastroenterol Nutr. 2014 Jun;58(6):795-806. doi: 10.1097/MPG.0000000000000239. J Pediatr Gastroenterol Nutr. 2014. PMID: 24231644
Effect of thalidomide on clinical remission in children and adolescents with refractory Crohn disease: a randomized clinical trial.
Lazzerini M, Martelossi S, Magazzù G, Pellegrino S, Lucanto MC, Barabino A, Calvi A, Arrigo S, Lionetti P, Lorusso M, Mangiantini F, Fontana M, Zuin G, Palla G, Maggiore G, Bramuzzo M, Pellegrin MC, Maschio M, Villanacci V, Manenti S, Decorti G, De Iudicibus S, Paparazzo R, Montico M, Ventura A. Lazzerini M, et al. Among authors: lionetti p. JAMA. 2013 Nov 27;310(20):2164-73. doi: 10.1001/jama.2013.280777. JAMA. 2013. PMID: 24281461 Clinical Trial.
Malignancy and mortality in pediatric patients with inflammatory bowel disease: a multinational study from the porto pediatric IBD group.
de Ridder L, Turner D, Wilson DC, Koletzko S, Martin-de-Carpi J, Fagerberg UL, Spray C, Sladek M, Shaoul R, Roma-Giannikou E, Bronsky J, Serban DE, Cucchiara S, Veres G, Ruemmele FM, Hojsak I, Kolho KL, Davies IH, Aloi M, Lionetti P, Veereman-Wauters G, Braegger CP, Trindade E, Wewer AV, Hauer A, Levine A; Porto IBD Working Group of ESPGHAN. de Ridder L, et al. Among authors: lionetti p. Inflamm Bowel Dis. 2014 Feb;20(2):291-300. doi: 10.1097/01.MIB.0000439066.69340.3c. Inflamm Bowel Dis. 2014. PMID: 24374875 Free article.
Phenotype and disease course of early-onset pediatric inflammatory bowel disease.
Aloi M, Lionetti P, Barabino A, Guariso G, Costa S, Fontana M, Romano C, Lombardi G, Miele E, Alvisi P, Diaferia P, Baldi M, Romagnoli V, Gasparetto M, Di Paola M, Muraca M, Pellegrino S, Cucchiara S, Martelossi S; SIGENP IBD Group. Aloi M, et al. Among authors: lionetti p. Inflamm Bowel Dis. 2014 Apr;20(4):597-605. doi: 10.1097/01.MIB.0000442921.77945.09. Inflamm Bowel Dis. 2014. PMID: 24569242
Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: effect of N-acetyl transferase polymorphisms.
Stocco G, Cuzzoni E, De Iudicibus S, Favretto D, Malusà N, Martelossi S, Pozzi E, Lionetti P, Ventura A, Decorti G. Stocco G, et al. Among authors: lionetti p. World J Gastroenterol. 2015 Mar 28;21(12):3571-8. doi: 10.3748/wjg.v21.i12.3571. World J Gastroenterol. 2015. PMID: 25834322 Free PMC article.
Severe Erosive Esophagitis Associated With a Short Course of Ibuprofen.
Paci M, Chiappini E, Trapani S, Resti M, Lionetti P. Paci M, et al. Among authors: lionetti p. J Pediatr Gastroenterol Nutr. 2015 Jul;61(1):e1. doi: 10.1097/MPG.0b013e3182a0e0bf. J Pediatr Gastroenterol Nutr. 2015. PMID: 26115432 No abstract available.
Use of Biosimilars in Paediatric Inflammatory Bowel Disease: A Position Statement of the ESPGHAN Paediatric IBD Porto Group.
de Ridder L, Waterman M, Turner D, Bronsky J, Hauer AC, Dias JA, Strisciuglio C, Ruemmele FM, Levine A, Lionetti P; ESPGHAN Paediatric IBD Porto Group. de Ridder L, et al. Among authors: lionetti p. J Pediatr Gastroenterol Nutr. 2015 Oct;61(4):503-8. doi: 10.1097/MPG.0000000000000903. J Pediatr Gastroenterol Nutr. 2015. PMID: 26154031
184 results